Hong Kong Stock Announcement Nuggets | Sanhua Intelligent Control's Net Profit Expected to Increase by 25%-50% YoY

Important matters:

Xiansheng Pharmaceutical (02096) signed an exclusive licensing agreement with IPSEN for SiM0613 (LRRC15 antibody-conjugated drug)

Yun Zhisheng (09678) released the “Shanhai‧Zhi Medical Big Model 5.0” version of the medical field expert model

Zhongchuang Zhiling (00564) plans to establish Zhongchuang Zhiling (Zhengzhou) Industrial Investment Partnership to specialize in foreign investment business

Brain Motion Aurora-B (06681): Participated in major national science and technology research projects and was approved by the Beijing Key Laboratory for Digital Medicine for Cognitive Disorders

Dipu Technology (01384) signed a strategic cooperation agreement with Mu Xi Co., Ltd.

Shimao Services (00873) plans to establish a partnership with Huludao Yongsheng

Hansaite-B (03378): Hong Kong public offering received 3074.09 times the subscription price of HK$32 per share

Easy Health (02661): The Hong Kong Public Offer received 1421.47 times the subscription price of HK$22.68 per share

Nobicam (02635): Hong Kong public offering received 188.74 times the subscription price of HK$80 per share

Operating performance:

Sanhua Intelligent Control (02050) Fa Yingxi expects net profit to return to mother for the year to increase by 25%-50% year-on-year

Cathay Pacific (00293): The number of passengers carried 2,530,400 in November increased 26% year-on-year

The total sales amount of Taobo (06110)'s retail and wholesale business in the third quarter was high year on year and the number of units fell